🔎 Trials Near Me

Akèy › Maladi fwa steatotik › North Carolina › Durham

Etid klinik pou Maladi fwa steatotik nan Durham, NC

8 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Durham
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Durham
Laj 18 a 80 · Tout sèks · Mizajou Oct 5, 2026 · NCT06318169

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Ap rekriteFaz 2
  • Duke Liver Center, Durham
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3
  • Duke University - Main Hospital and Clinics, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3
  • Akero Clinical Study Site, Durham
  • Akero Clinical Study Site, Chapel Hill · 10 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Chapel Hill · 10 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698

Androgens and NAFLD Longitudinal Cohort Study

Ap rekriteEtid obsèvasyon
  • Duke University, Durham
Laj 18 a 42 · Fanm · Mizajou Apr 13, 2026 · NCT06124261

Siemens Biomarker Multi-modality

Ap rekrite
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT07495332

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.